World Party Day encourages collective celebration—not tied to profit, obligation, or hierarchy. It’s about recognizing joy as a unifying force across cultures, cities, and communities. The concept is simple: if people celebrated together more often, connection would replace division.
In practice, this day isn’t about excess—it’s about shared energy. Music, movement, conversation, and presence all count. The real party is participation.
Vibes
Global rhythm. Shared energy.
How to Celebrate
• Host or join a gathering • Play music that moves people • Dance without agenda • Celebrate community
Pulse Check
Who do you celebrate life with?
Joy multiplies when shared.
Interesting Facts
• The idea originated from a call for global celebration • It’s observed in multiple countries • Music is the most common connector
The Pink Moon marks April’s full moon and takes its name from early spring wildflowers that bloom across North America—not from the moon’s appearance itself. Traditionally associated with renewal, growth, and seasonal shifts, this lunar moment has long served as a natural checkpoint between winter’s closure and spring’s acceleration.
In modern culture, the Pink Moon has become a pause button. It’s a reminder that cycles matter—rest, growth, release, repeat. While the moon itself keeps perfect time, how we align with it is optional, intentional, and personal. For many, this full moon represents momentum with awareness.
Vibes
Reset energy. Clean transitions. Forward motion.
How to Observe
• Reflect on what’s beginning to grow in your life • Release habits that no longer align • Spend time outdoors after sunset • Set intentions rooted in consistency
Pulse Check
What’s quietly growing in your life right now?
Progress doesn’t always announce itself. Sometimes it shows up gradually, like spring itself.
Interesting Facts
• The Pink Moon often coincides with early spring blooms • It’s one of the earliest full moons of the year • Lunar cycles have guided agriculture for centuries
Analysis: Cannabis Legalization Laws Associated With Lower Crime Rates
Fairfield, CT: The enactment of laws legalizing cannabis for either medical or adult-use purposes is associated with declining crime rates over time, according to findings published in the scientific journal Economic Modeling.
Researchers affiliated with the Jack Welch College of Business at Sacred Heart University in Connecticut and Barnard College in New York evaluated the relationship between statewide cannabis policies and crime rates nationwide.
Consistent with prior studies, they reported that liberalized marijuana laws were associated with reductions in overall criminal activity. Specifically, the adoption of medical cannabis legalization is associated with reduced property crime, whereas adult-use legalization is associated with decreases in violent crime. These trends become more pronounced over time.
“The overarching result from our [study] is that medical legalization reduces property crime, while recreational legalization reduces violent crime. Such effects support the … hypothesis that legalization drives out crime,” the study’s authors concluded. “The diverse and potentially time-varying impacts of medical and recreational legalization raise a cautionary note for policymakers: those considering legalization should wait a few years before pronouncing on the cost-benefit impact, focus on the specific type of legalization, and study closely the outcomes from similar states.”
Previous studies have similarly determined that cannabis legalization is associated with improvements in police clearance rates, particularly for those cases involving violent offenses.
Full text of the study, “How does marijuana legislation affect crime? Medical and recreational laws across 50 states,” appears in Economic Modeling.
Canada: Alcohol Sales Continue Historic Decline While Cannabis Sales Rise
Ottawa, Ontario: Sales of alcohol and cannabis in Canada are on opposite trajectories, according to data provided by Statistics Canada, the national statistical agency of the Canadian government.
For the fiscal year ending March 31, 2025, sales of adult-use cannabis products increased 6.5 percent. By contrast, alcohol sales revenue declined by 1.6 percent.
Canadians purchased $5.5 billion worth of cannabis products in the last fiscal year, with sales of herbal cannabis products comprising approximately 60 percent of all sales.
Canada legalized the adult-use marijuana market in 2018.
Data from several US jurisdictions, including California, have identified a relationship between legal cannabis access and decreasing alcohol consumption. Survey data published in 2024 in The Harm Reduction Journal found that 60 percent of cannabis consumers acknowledge using it to reduce their alcohol intake.
Complete data sets are available from Statistics Canada.
Study: Plant-Derived Cannabis Extracts More Effective Than Dronabinol in Elderly Patients With Chronic Pain
Nürnberg, Germany: Plant-derived cannabis extracts containing standardized percentages of CBD and THC are more effective and tolerable than dronabinol (synthetic oral THC) in older pain patients, according to data published in the Journal of Pain Research.
German researchers assessed the efficacy of CBD-dominant extracts versus dronabinol in matched cohorts of 484 elderly (age 65 or older) patients with either chronic or refractory pain conditions. Study participants consumed the products for 24 weeks.
Both treatments were associated with “clinically relevant improvements” in patients’ pain disability, sleep, quality of life, psychological well-being, and use of analgesics. However, patients consuming plant-derived extracts exhibited greater overall levels of improvement. Participants taking dronabinol were also more likely to drop out of the study.
The study’s authors concluded: “To our knowledge, [this study] represents the first large real-world evaluation of oral cannabis-based medicines (CBM) specifically in older patients with chronic pain. Over a 24-week observation period, both CBD > THC and THC/DRO [dronabinol] therapies were associated with clinically relevant improvements. … However, the extent of improvement and the rates of ADR [adverse drug reaction]-related discontinuations differed between the two treatment groups, with CBD > THC being associated with more favorable outcomes. These findings expand the limited evidence based on the use of CBM in elderly patients and complement previous clinical and observational studies on cannabinoids in pain medicine.”
Survey data finds that seniors are increasingly turning to cannabis, typically for medical purposes. Most older adults acknowledge holding positive perceptions about cannabis, and several recent studies show that its use is frequently associated with quality of life improvements among seniors.
Full text of the study, “CARE – A retrospective, dual-cohort, 24-week real-world study from the German pain E-registry on the effectiveness and safety of CBD-dominant oral cannabis extracts versus THC/dronabinol in older patients with chronic pain,” appears in the Journal of Pain Research.
Colorado: Data Finds No Evidence of Underage Cannabis Sales at Licensed Retailers
Denver, CO: Employees at licensed cannabis retailers strictly enforce the state’s minimum age requirements and nearly always deny entry to those without proper identification, according to data provided by state regulators.
Annual data provided by Colorado’s Marijuana Enforcement Division finds that retailers denied entry 99 percent of the time to patrons lacking proper proof of age. That result is consistent with data from other adult-use states, including California and Washington, finding that state-licensed cannabis retailers are more likely than alcohol proprietors to deny those without proper ID entry to their facilities.
Commenting on the findings, NORML’s Deputy Director Paul Armentano said, “Regulation works. Illicit marijuana providers don’t ask for or check for ID, but licensed businesses most certainly do. States’ real-world experience with adult-use marijuana legalization affirms that it is being implemented in a way that provides regulated access for adults while simultaneously limiting youth access and misuse.”
Federally funded survey data compiled by the University of Michigan in December reports that marijuana use by adolescents has fallen dramatically since states began regulating adult-use cannabis markets and now stands at or near historic lows.
New York, NY: The adoption of statewide adult-use marijuana legalization laws is associated with declines in illicit market cannabis seizures by law enforcement and likely reduces the size of the unregulated marketplace, according to data published in the International Journal of Drug Policy.
Researchers affiliated with Columbia University and New York University assessed the relationship between legalization laws and annual changes in cannabis seizures by state and federal law enforcement from 2010 to 2023.
Investigators determined that adult-use legalization “was associated with a significant decrease in cannabis seizures,” both in the short-term and long-term.
The study’s authors concluded: “Findings showed a 45 percent relative reduction in mean counts of state law enforcement cannabis seizures in states that adopted RCL [recreational cannabis laws] in addition to MCL [medical cannabis laws], even after controlling for secular trends and pre-existing state differences. … Taken together, findings from this study support the possibility that RCLs, beyond only MCLs, may help to reduce the size of the illegal cannabis market.”
In Canada, which legalized marijuana sales nationwide in 2018, nearly 80 percent of cannabis consumers have transitioned from unregulated markets to the legal market. According to a 2023 survey of US consumers, 52 percent of adults residing in legal states said that they primarily sourced their cannabis products from retail establishments.
Most recently, data provided by the Massachusetts Cannabis Control Commission reported that over 70 percent of consumers purchase their cannabis at a store. “Residents turn away from the illicit market when safe, well-regulated options are available,” the Commission’s Executive Director Travis Ahern said.
Full text of the study, “Cannabis legalization and law enforcement drug seizures: A state-level analysis of cannabis policy effects on cannabis seizures in the United States,” appears in International Journal of Drug Policy.
Analysis: Cannabis Use Associated With Significant Reductions in Patients’ Daily Anxiety
Fort Myers, FL: The consumption of state-authorized medical cannabis products is associated with significant decreases in daily anxiety levels, according to longitudinal data published in the journal Nature: Scientific Reports.
Investigators affiliated with Florida Gulf Coast University assessed cannabis’ efficacy in a cohort of 416 patients with a history of anxiety. Participants’ anxiety levels were initially assessed at baseline. Daily shifts in anxiety levels were assessed for the following 45 days. On some days, subjects consumed state-licensed medical cannabis products. At other times, subjects engaged in meditation and other activities to moderate their anxiety.
Patients reported the greatest mitigation in their anxiety on the days they consumed cannabis.
The study’s authors concluded: “Results showed that across all 45 days and participants, MC [medical cannabis] use was the biggest factor in alleviating anxiety. … Investigating how participants administered their MC revealed no effect of route of administration on anxiety relief. … Future work should help paint a clearer picture of how initiating and maintaining MC use helps individuals deal with daily anxiety levels.”
In a previous study of state-registered medical cannabis patients, over 90 percent of respondents said that cannabis helped to relieve their anxiety. Survey data consistently reports that consumers are most likely to use cannabis for purposes of mitigating pain and anxiety.
Full text of the study, “Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days,” appears in Nature: Scientific Reports.
Florida: Supreme Court Sides With DeSantis Administration in Legalization Ballot Measure Fight
Tallahassee, FL: The Supreme Court will not entertain arguments challenging the DeSantis administration’s decision to invalidate tens of thousands of signatures in support of a proposed 2026 adult-use marijuana legalization ballot measure.
Election officials in February determined that petitioners from the Smart & Safe Florida campaign failed to turn in the necessary number of valid signatures to qualify for the November ballot. The campaign filed a legal challenge to that decision, arguing that state officials improperly dismissed tens of thousands of signatures that should have been counted.
Last week, the Court announced that it would not consider the petitioners’ challenge – stating, “No motion for rehearing will be entertained by the Court.” No further explanation was provided.
Petitioners qualified a similar measure on the 2024 ballot. That proposal gained 56 percent of the vote, shy of the 60 percent threshold required to pass a constitutional amendment in Florida. (Florida is the only state that requires citizen-initiated measures to gain more than a simple majority.)
The DeSantis administration vigorously opposed both efforts. In May, Gov. DeSantis signed legislation making it harder for parties to qualify measures for the electoral ballot. Earlier this year, state election officials audited the work of several counties, which they alleged had not properly verified voters’ signatures. State officials also launched a criminal probe to investigate the actions of various petitioners involved with the Smart & Safe campaign. Separately, the Attorney General’s office had previously challenged the wording of the proposed measure in court, calling it “unconstitutional.”
Historically, Florida has been among the states with the highest number of annual marijuana-related arrests. Under state law, possession of 20 grams or less of marijuana is a criminal misdemeanor, punishable by up to one year in jail and a $1,000 fine. Possessing greater amounts is a felony offense, punishable by up to five years in prison.
Georgia: Lawmakers Advance Legislation Expanding Medical Cannabis Access To Qualified Patients
Atlanta, GA: Lawmakers have amended and approved legislation, Senate Bill 220, significantly expanding the state’s limited medical cannabis access law.
Under existing law, qualified patients are limited to infused “low THC oil” products containing no more than five percent THC. The proposed measure allows patients to obtain “medical cannabis” products “containing a cumulative total of 12,000 milligrams or less of THC.” It also permits products to be available in formulations that may be consumed via vaporization. It also expands the pool of patients eligible to receive medical cannabis authorizations to include those diagnosed with lupus, severe arthritis, and severe insomnia, among other conditions.
Senate members initially passed the bill on March 6th by a vote of 39 to 17. House members amended and passed the bill days later by a vote of 138 to 21. The Senate signed off on the changes this week.
Georgia lawmakers approved legislation in 2015 legalizing the possession of non-herbal, low-THC oils for authorized patients. However, regulators failed to license dispensaries to provide these products until 2023.
Over 33,000 patients are currently enrolled in Georgia’s medical cannabis access program.
Mississippi: Bill Providing Doctors With Greater Discretion To Recommend Medical Cannabis Advanced to Governor’s Desk
Jackson, MS: Legislation (House Bill 1152) providing physicians with greater discretion to recommend medical cannabis has passed both legislative chambers with veto-proof majorities. The measure now awaits action by Republican Gov. Tate Reeves.
Under current law, patients are only eligible for medical cannabis therapy if they suffer from one of a limited list of qualifying conditions. Under HB 1152: The Right to Try Medical Cannabis Act, healthcare practitioners may submit a petition to the Department of Health requesting authorization for patients who are suffering from a non-qualifying illness. State officials will then have 45 days to either approve or deny the request. All decisions are final and cannot be appealed.
Members of the Senate initially approved the bill by a vote of 102 to 14. House members amended and approved the bill 34 to 7. This week, Senators concurred with the House’s changes by a vote of 102 to 14.
The Act is scheduled to take effect on July 1, 2026.
Separate legislation (HB 895) extending the validity period of a practitioner’s medical cannabis recommendation was also sent to the Governor.
Mississippi lawmakers approved legislation in 2022 regulating medical cannabis access. Nearly 60,000 patients are currently enrolled in the program.
